TP53 and cancer: TP53 mutation is more prevalent among patients with LUSC than patients with LUAD (57–65% versus 40–41%)28,29, and the frequency of TP53 mutation in the lungs of patients with cancer who smoke is also higher than in never smokers (48% versus 36%)29.